
    
      Primary Objectives

        1. To estimate the frequency of HFS following treatment with capecitabine as modulated by
           the unilateral local application of eniluracil containing ointment.

        2. To assess any eniluracil dose response relationship in prevention of HFS.

        3. To evaluate any potential toxicity of eniluracil ointment.
    
  